Cited by 57Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychological Treatments and Disorders

Defining anxious depression: going beyond comorbidity

Open access
Silverstone, Peter H, von Studnitz, Erica·2003·The Canadian Journal of Psychiatry

Abstract

OBJECTIVE: Since publication of the DSM-IV, there remains a group of patients with depression and anxiety symptoms who are not well classified. We therefore wanted to determine more accurately the type of patients best described by the term "anxious depression." We also wanted to review the literature to assess the most appropriate treatment(s) for these patients. METHOD: We surveyed the medical literature published after 1994 for all articles containing the relevant terms and assessed all possible articles in detail to determine those relevant to the diagnosis and those that involved relevant clinical studies. RESULTS: The term anxious depression can encompass 3 groups of patients: those with comorbid major depressive disorder (MDD) and an anxiety disorder, those with MDD but with subthreshold anxiety symptoms, and those with subthreshold depressive and subthreshold anxiety symptoms (also called mixed anxiety and depressive disorder). CONCLUSIONS: Based upon our literature review, we believe that the term anxious depression should only be used for the second group; that is, those patients with an MDD and subthreshold anxiety symptoms. From our literature review to determine the most appropriate treatment for this group of patients, it appears likely that drugs inhibiting the reuptake of both noradrenaline and serotonin may have greater clinical utility than single-action drugs such as the selective serotonin reuptake inhibitors (SSRIs). However, it is also clear that much more research needs to be undertaken in this important patient group so that we can better understand its prevalence, clinical features, and treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/070674370304801006

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Roy-Byrne P. Anxiety in primary care depression: how does it lead to poor out- comes and what can we do about it? Gen Hosp Psychiatry 1999;21:151-3.
  2. Blomhoff S, Haug TT, Kellstrom K, Holme I, Humble M, Madsbu HP, and oth- ers. Randomized controlled general practice trial of sertraline, exposure therapy and combined treatment in generalized social phobia. Br J Psychiatry 200;179:23-30.
  3. Goldberg DP. The management of anxious depression in primary care. J Clin Psychiatry 1999;60:39-42.
  4. Silverstone PH., Ravindran A. Efficacy and tolerability of once-daily venlafaxine XR vs fluoxetine in depressed outpatients with concomitant anxiety. J Clin Psychiatry 1999;60:22-8.

Cited by

Sorted by citations

Authors
Silverstone, P. H., & von Studnitz, E.
Affiliations
  • University of Alberta (CA)
  • Integra-Pharm, Narberth, Pennsylvania
Corresponding author
Silverstone, Peter H
Venue
The Canadian Journal of Psychiatry
Published
2003-11
Volume
48
Issue
10
Pages
675-680
ISSN
  • 0706-7437 (ISSN-L)
  • 1497-0015
OpenAlex
W2145232823
Cited by
57
References
57
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 6 · 2017: 4 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 1
FWCI
0.27
Type
journal article
Language
en
Open access
Locations
  • The Canadian Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
Keywords
anxious depression, major depressive disorder, mixed anxiety-depressive disorder, comorbidities, diagnosis, treatment, selective serotonin reuptake inhibitors, DSM-IV
MeSH terms
Anxiety, Clinical Trials as Topic, Major Depressive Disorder, Humans, Comorbidity, Selective Serotonin Reuptake Inhibitors, Diagnostic and Statistical Manual of Mental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review